HCA
Income statement / Annual
Last year (2025), HCA Healthcare Inc's total revenue was $75.60 B,
an increase of 7.08% from the previous year.
In 2025, HCA Healthcare Inc's net income was $6.78 B.
See HCA Healthcare Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$75.60 B |
$70.60 B |
$64.97 B |
$60.23 B |
$58.75 B |
$51.53 B |
$51.34 B |
$46.68 B |
$43.61 B |
$41.49 B |
| Cost of Revenue |
$44.23 B
|
$41.93 B
|
$39.39 B
|
$37.06 B
|
$36.26 B
|
$8.37 B
|
$8.48 B
|
$7.72 B
|
$7.32 B
|
$6.93 B
|
| Gross Profit |
$31.37 B
|
$28.68 B
|
$25.58 B
|
$23.18 B
|
$22.49 B
|
$43.16 B
|
$42.86 B
|
$38.95 B
|
$36.30 B
|
$34.56 B
|
| Gross Profit Ratio |
0.42
|
0.41
|
0.39
|
0.38
|
0.38
|
0.84
|
0.83
|
0.83
|
0.83
|
0.83
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$8.00 B
|
$31.17 B
|
$29.49 B
|
$27.69 B
|
$26.78 B
|
$23.87 B
|
$23.56 B
|
$21.43 B
|
$20.06 B
|
$18.90 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.00 B
|
$31.17 B
|
$29.49 B
|
$27.69 B
|
$26.78 B
|
$23.87 B
|
$23.56 B
|
$21.43 B
|
$20.06 B
|
$18.90 B
|
| Other Expenses |
$11.41 B
|
-$13.04 B
|
-$13.54 B
|
-$13.56 B
|
-$13.97 B
|
$12.03 B
|
$12.08 B
|
$10.89 B
|
$10.18 B
|
$9.46 B
|
| Operating Expenses |
$19.41 B
|
$18.13 B
|
$15.95 B
|
$14.12 B
|
$12.81 B
|
$35.90 B
|
$35.64 B
|
$32.31 B
|
$30.24 B
|
$28.36 B
|
| Cost And Expenses |
$63.64 B
|
$60.06 B
|
$55.34 B
|
$51.18 B
|
$49.07 B
|
$44.27 B
|
$44.12 B
|
$40.04 B
|
$37.56 B
|
$35.29 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.25 B
|
$2.06 B
|
$1.94 B
|
$1.74 B
|
$1.53 B
|
$1.56 B
|
$1.84 B
|
$1.77 B
|
$1.67 B
|
$1.60 B
|
| Depreciation & Amortization |
$3.52 B
|
$3.31 B
|
$3.08 B
|
$2.97 B
|
$2.85 B
|
$2.72 B
|
$2.60 B
|
$2.28 B
|
$2.13 B
|
$1.97 B
|
| EBITDA |
$15.60 B |
$13.90 B |
$12.72 B |
$13.29 B |
$14.25 B |
$9.74 B |
$9.66 B |
$9.37 B |
$8.20 B |
$8.48 B |
| EBITDA Ratio |
0.21
|
0.2
|
0.2
|
0.22
|
0.24
|
0.19
|
0.19
|
0.2
|
0.19
|
0.2
|
| Operating Income Ratio |
0.16
|
0.15
|
0.15
|
0.15
|
0.16
|
0.14
|
0.14
|
0.14
|
0.14
|
0.15
|
| Total Other Income/Expenses Net |
-$2.13 B
|
-$2.02 B
|
-$1.92 B
|
-$473.00 M
|
$155.00 M
|
-$1.83 B
|
-$1.97 B
|
-$1.31 B
|
-$1.68 B
|
-$1.39 B
|
| Income Before Tax |
$9.83 B
|
$8.52 B
|
$7.71 B
|
$8.58 B
|
$9.83 B
|
$5.43 B
|
$5.24 B
|
$5.34 B
|
$4.38 B
|
$4.81 B
|
| Income Before Tax Ratio |
0.13
|
0.12
|
0.12
|
0.14
|
0.17
|
0.11
|
0.1
|
0.11
|
0.1
|
0.12
|
| Income Tax Expense |
$2.05 B
|
$1.87 B
|
$1.62 B
|
$1.75 B
|
$2.11 B
|
$1.04 B
|
$1.10 B
|
$946.00 M
|
$1.64 B
|
$1.38 B
|
| Net Income |
$6.78 B
|
$5.76 B
|
$5.24 B
|
$5.64 B
|
$6.96 B
|
$3.75 B
|
$3.51 B
|
$3.79 B
|
$2.22 B
|
$2.89 B
|
| Net Income Ratio |
0.09
|
0.08
|
0.08
|
0.09
|
0.12
|
0.07
|
0.07
|
0.08
|
0.05
|
0.07
|
| EPS |
28.62 |
22.27 |
19.24 |
19.44 |
21.51 |
11.08 |
10.27 |
11.04 |
6.33 |
7.8 |
| EPS Diluted |
28.38 |
22 |
18.96 |
19.15 |
21.16 |
10.93 |
10.07 |
10.66 |
5.95 |
7.3 |
| Weighted Average Shares Out |
$230.71 M
|
$258.60 M
|
$272.40 M
|
$290.35 M
|
$323.32 M
|
$339.43 M
|
$341.21 M
|
$342.90 M
|
$350.09 M
|
$370.54 M
|
| Weighted Average Shares Out Diluted |
$230.71 M
|
$261.81 M
|
$276.41 M
|
$294.67 M
|
$328.75 M
|
$345.37 M
|
$348.23 M
|
$355.30 M
|
$372.22 M
|
$395.85 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
